Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00168909
Status:
COMPLETED
Last Update Posted:
2008-05-09
First Post:
2005-09-09
Brief Title:
Influence of Alfacalcidol on Falls in OsteopenicOsteoporotic Postmenopausal Women ALFA Study
Sponsor:
Charite University Berlin Germany
Organization:
Charite University Berlin Germany
Study Overview
Official Title:
Influence of Alfacalcidol on Falls in Elderly Postmenopausal Alendronate-Treated OsteopenicOsteoporotic Women With High Risk of Falls
Status:
COMPLETED
Status Verified Date:
2008-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the effect of alfacalcidol 1 µg daily on the number of fallers in postmenopausal alendronate-treated osteopenic or osteoporotic women
primary outcome number of fallers patients with at least one locomotor fall inclmixed falls
primary outcome number of fallers patients with at least one locomotor fall inclmixed falls
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None